Covid-19 vaccine stocks rose after AstraZeneca resumed final-phase trials in the U.K. after a six-day pause, and Pfizer and BioNTech said they filed to expand their final-phase testing.

The post Covid Roundup: Pfizer Widens Test; AstraZeneca Resumes Late-Stage Trial appeared first on Investor's Business Daily.